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Abstract 
The addition of corticotropin-releasing factor (CRF) to molluscan hemocytes induces the release of biogenic amines (norepinephrine, pinephrine, 
dopamine), a phenomenon we have considered as an ancestral type of stress response [( 1992) Gen. Comp. Endocrinol. 87, 3543601. A similar but 
less significant response was observed following the addition of interleukin-2 (IL-2). Pre-incubation of hemocytes with IL-2 or anti-IL-2 monoclonal 
antibody significantly reduced or completely eliminated the CRF-induced release of biogenic amines. Further direct evidence of competition between 
CRF and IL-2 was revealed by immunocytochemical and cytofluorimetric analysis. The data are compatible with the presence of a unique (ancestral?) 
receptor on molluscan hemocytes, capable of binding both CRF and IL-2, two key molecules of the neuroendocrine and immune system, respectively. 
Key wards: Corticotropin-releasing factor; Interleukin-2; Molluscan hemocyte; Biogenic amines; Stress response; Cytokine receptor 
1. Introduction 
Stress response is an integrated reaction to agents 
which threaten body homeostasis. Besides activation of 
the hypothalamic-pituitary-adrenal xis, several studies 
have suggested that the immune system is also involved 
in the stress response. Using invertebrate models, we and 
others have demonstrated that corticotropin-releasing 
factor (CRF) and adrenocorticotropin hormone 
(ACTH) are present in invertebrate immune cells (he- 
mocytes) and cell-free hemolymph, and that they medi- 
ate immune responses such as cell migration and 
phagocytosis [l-3]. Moreover, we have demonstrated 
that molluscan hemocytes are also able to exert an ances- 
tral type of stress response (release of biogenic amines) 
when exposed to CRF and ACTH [4,5]. An intriguing 
relationship appears to exist between cytokines and 
stress response in mammals [6]. Wishing to trace the 
evolutionary basis of this relationship, and taking into 
account recent evidence of the presence of cytokine-like 
molecules in invertebrates [7-l I], we investigated the 
possible role of cytokines in an invertebrate stress re- 
sponse. 
Hemocytes from two invertebrates were used, i.e. 
Planorbarius corneus and Viviparus ater. In both mol- 
lusts, phagocytic hemocytes contain pro-opiomelano- 
cortin (POMC)-derived peptide-like molecules, such as 
ACTH and j?-endorphin, and the enzymes responsible 
for the biosynthesis of biogenic amines [1,5,12]. The re- 
sults obtained suggest hat IL-2 is capable of inducing 
the release of biogenic amines from the hemocytes of 
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both molluscs and of interferring with the CRF-induced 
release of biogenic amines. The results can be explained 
by assuming the presence on the plasma membrane of 
the molluscan hemocyte of a common receptor able to 
bind both IL-2 and CRF. 
2. Materials and methods 
2.1. Specimens 
Adult specimens of Planorbarius corneus (L.) and Viviparus ater 
(Cristofori and Jan) maintained in dechlorinated freshwater at room 
temperature were used. 
2.2. Determination of the biogenic amines 
Hemolymph of p cornens and l! ater was divided into six portions 
(3 ml each one) and placed in plastic tubes. In the first tube (control 
sample), snail saline solution (SSS) (300 ~1) [13] was added, in the 
second, human CRF (Sigma Chem. Co., St. Louis, USA) (IO-* M final 
concentration), and in the third, human recombinant interleukin-2 (IL- 
2) (Boehringer, Mannheim, Germany) (20 U/ml final concentration). 
The sample in the fourth tube was preincubated with IL-2 (20 U/ml final 
concentration) for 2 h before adding CRF (IO-* M final concentration), 
while those in the fifth and sixth tubes were incubated with anti-IL-2 
monoclonal antibody (mAb) (Serva, Heidelberg, Germany) (1:l) for 2 
h, before adding CRF (IO-* M final concentration) to the sixth tube 
only. All the tubes were incubated for 20 min at room temperature and 
immediately centrifuged (600 x g for 15 min). After centrifugation, the 
supematant (serum) and the pellet (hemocytes) were collected, and the 
amount of biogenic amines in the serum was immediately determined 
by HPLC. Serum samples were prepared and analyzed by the addition 
of activated aluminium oxide to the Clin-Rep-Catecholamine Kit 
(Pharma Vertriebs GmbH and Co. KG, Munich, Germany), as de- 
scribed elsewhere [14], and subsequently treated and analyzed as previ- 
ously reported [4]. Each experiment was carried out at least three times. 
2.3. Immunocytochemicai procedures 
Hemolymph of I! ater was collected as previously described [15]. The 
hemocytes were cytocentrifuged (Cytospin 2 Cytocentrifuge, Shandon) 
on a slide at 1000 ‘pm for 10 min and air-dried. The unfixed hemocytes 
were then processed by an immunocytochemical procedure, as de- 
scribed elsewhere [16]. Hemocytes were treated with anti-IL-2 mAb 
(1:lO) and anti-CRF polyclonal antibody (pAb) (1:250) (Accurate 
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Chemical and Scientific Corp., New York, USA) overnight at 4°C. The 
reaction was visualized by avidin-biotin-peroxidase complex [I 71. Con- 
trols were performed either by omitting the primary antibody or by 
testing the antibody on the hemocytes after pre-absorption in liquid 
phase with their homologous antigens (in excess) overnight at 4°C. 
Nuclei were counterstained with hematoxylin. Anti-IL-2 mAb was also 
tested on the hemocytes after pre-absorption with CRF (10m6 M). 
2.4. Cytofluorimetric analysis 
Hemocytes from K ater were incubated with optimal concentrations 
of anti-IL-2 mAb for 30 min at 4°C washed with cold SSS, incubated 
with a TRITC-conjugated rabbit anti-mouse Ig for 30 min at 4°C 
washed with cold SSS and analyzed with a FACSCAN cytofluorimeter, 
as described elsewhere [2]. In some cases, staining with anti-IL-2 mAb 
was performed in the presence of 5 x IO-’ M CRF or of 20 U/ml IL-2. 
a 
3. Results and discussion 
Table 1 shows that, as expected, release of biogenic 
amines, and particularly of norepinephrine (NA) and 
epinephrine (A), was observed when P corneus or K ater 
hemocytes were incubated with CRF. However, when 
cells were pre-incubated with IL-2, this effect was drasti- 
cally reduced. IL-2 alone was also able to induce a re- 
lease of biogenic amines, but the effect was much less 
potent than that observed with CRF. These data would 
suggest hat CRF and IL-2 bind to the same receptor but 
with a different affinity, probably much higher for CRF 
than for IL-2. The addition of anti-IL-2 mAb did not, per 
se, provoke the release of biogenic amines. However, this 
antibody was able to inhibit the CRF-induced release of 
NA and A. We hypothesized that IL-2 and CRF could 
share at least one epitope, causing competition for a 
common receptor on molluscan hemocytes, recognized 
by anti-IL-2 mAb. To further test this hypothesis, im- 
munocytochemical and cytofluorimetric analysis were 
performed. Hemocytes from IX ater were positively 
stained when treated with antibodies to IL-2 and CRF 
Fig. 1. (ad) Positive immunoperoxidase staining of molluscan he- 
mocytes to anti-IL-2 mAb (a) and anti-CRF pAb (b). Negative control 
for anti-IL-2 mAb (c). Negative immunostaining of hemocytes for the 
anti-IL-2 mAb after pre-absorption with CRF (d). Nuclei were counter- 
stained with hematoxylin. Bar = IO pm. 
(Fig. la,b). As expected, when the staining was per- 
formed with an anti-IL-2 mAb pre-absorbed with IL-2, 
a negative result was observed (Fig. Ic), however, the 
same inhibition was also observed when anti-IL-2 mAb 
was pre-absorbed with CRF (Fig. Id). Further proof of 
the competition between CRF and IL-2 was revealed by 
cytofluorimetric analysis: anti-IL-2 mAb was able to 
stain molluscan hemocytes (Fig. 2a), but this reaction 
was inhibited not only in the presence of IL-2, as ex- 
pected, but also with CRF (Fig. 2b). 
Table 1 
Concentrations of biogenic amines determined by HPLC in cell-free hemolymph from Pianorbarius corneus and Viviparus ater after the addition to 
hemolymph of 10-s M CRF, IL-2 (20 U/ml), CRF after pre-incubation with IL-2 and anti-IL-2 mAb 
Addition of 
Saline CRF IL-2 IL-2 + CRF anti-IL-2mAb anti-IL-2mAb 
+ CRF 
Na (%) fl corneus 28.0 f 7.6” 293.0 + 31.6** 70.0 f 18.1* 284.0 + 28.8** 31.0? 10.4 33.0 f 7.0 
(100)b (1046) (250) (1015) (111) (118) 
l! ater 131.0 f 16.5 394.0 f 36.0** 250.0 f 28.3** 349.0 + 39.8** 143.0 f 24.4 137.0 k 30.7 
(100) (301) (191) (266) (109) (106) 
A @) P corneus 87.0 f 16.9 187.0 + 25.0** 145.0 f 14.3* 152.0 + 28.8* 96.0 +_ 31.4 103.0 f 26.0 
(100) (215) (167) (175) (110) (118) 
V ater 92.0 f 24.5 299.0 + 45.2+* 219.0 f 38.0** 312.0 + 37.0** 93.0 2 35.2 109.0 + 20.5 
(100) (325) (238) (339) (101) (118) 
DA (%) f corneus 246.0 f 24.6 325.0 f 22.9* 250.0 + 17.6 296.0 + 21.1 257.0 + 22.0 267.0 + 23. I 
000) (132) (102) (120) (104) (108) 
r/: ater 380.0 + 22.4 512.0 f 50.1* 417.0 + 41.7 524.0 + 25.5** 422.0 + 38.6 426.0 f 51.9 
(100) (135) (110) (138) (111) (112) 
NA = norepinephrine; A = epinephrine; DA = dopamine. “The mean f standard deviation of three experiments is shown. bControl values are taken 
as 100%. **P < 0.01 vs. control (saline); *P < 0.05 vs. control (saline). Statistical analysis was performed by Student’s f-test. 
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Fig. 2. (a-b) Identification by a FACSCAN cytofluorimeter of IL-2-like 
molecules on molluscan hemocyte plasma membrane by Anti-IL-2 
mAb (a) and competition of this antibody with IL-2 or CRF (b). 
Ordinate = cell number; abscissa = fluorescence intensity. Data refer to 
one experiment representative of 4. 
In conclusion, our main findings suggest hat IL-2 and 
CRF bind to the same receptor on molluscan hemocyte 
plasma membrane. The nature of this molluscan recep- 
tor is unknown. A possible scenario of this intriguing 
relationship between CRF, IL-2 and IL-2 receptors on 
snail hemocytes could be as follows. In basal conditions, 
one type of receptor able to bind either IL-2- or CRF-like 
molecules with low or high affinity, respectively, could 
be present on the plasma membrane of snail hemocytes. 
This occupancy would be insufficient to give an appre- 
ciable release of biogenic amines. The addition of IL-2 
or CRF might provoke the release of biogenic amines, 
and this phenomenon would be greater with CRF owing 
to its higher affinity for the receptor on hemocyte mem- 
branes. Such a situation would explain why the pre- 
incubation with both IL-2 and anti-IL-2 mAb signifi- 
cantly reduced the CRF-induced release of biogenic 
amines. In particular, anti-IL-2 mAb, which can bind to 
IL-2 and CRF present on the hemocyte membrane, 
would be unable to provoke amine release, leaving most 
of the antibody molecules free and able to bind to CRF, 
so inhibiting the CRF-induced release of the amines. 
The fact that the IL-2 receptor can be involved in the 
binding of molecules other than IL-2 is not unprece- 
dented. It has been recently demonstrated that in mam- 
malian cells the y chain of the IL-2 receptor is function- 
ally involved in the IL-4 and IL-7 receptor complex 
[18-201. Our findings enlarge the number of potential 
candidate ligands for the IL-2 receptor, suggesting that 
this phenomenon has a long evolutionary history. These 
results are probably the first demonstration that an im- 
21 
portant cytokine, IL-2, a crucial hormone for the stress 
response, CRF, and their receptors may have co- 
evolved. In any case, these data represent new evidence 
in favour of the strict relationship between the immune 
and neuroendocrine systems, and particularly of our hy- 
pothesis of the ‘mobile immune-brain’ [2,5]. Co-evolu- 
tion of ligand- receptor pairs has been recently described 
for LH and FSH receptors [21]. 
Further work is needed to ascertain whether IL-2 and 
CRF derive from a primordial molecule and whether 
their receptors share a common primordial origin. 
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